The Effects of Contact Lenses With Experimental Dye on Visual Function - Trial NCT03556579
Access comprehensive clinical trial information for NCT03556579 through Pure Global AI's free database. This phase not specified trial is sponsored by Johnson & Johnson Vision Care, Inc. and is currently Completed. The study focuses on Ametropia. Target enrollment is 62 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Johnson & Johnson Vision Care, Inc.
Timeline & Enrollment
N/A
May 15, 2018
Sep 20, 2018
Primary Outcome
Two-Point Light Spread Function,Halos,Starburts
Summary
This is a single-site, two-visit, contralateral, non-dispensing, randomized, controlled and
 subject-masked study to measure potential benefits of the new UV blocker.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT03556579
Device Trial